Low RAI2 expression is a marker of poor prognosis in breast cancer

被引：0
|
作者：
Sayaka Nishikawa
Yasuaki Uemoto
Tae-Sun Kim
Tomoka Hisada
Naoto Kondo
Yumi Wanifuchi-Endo
Takashi Fujita
Tomoko Asano
Yusuke Katagiri
Mitsuo Terada
Akiko Kato
Yu Dong
Hiroshi Sugiura
Katsuhiro Okuda
Hiroyuki Kato
Satoshi Osaga
Satoru Takahashi
Tatsuya Toyama
机构：
[1] Nagoya City University Graduate School of Medical Sciences,Department of Breast Surgery
[2] Nagoya City University Graduate School of Medical Sciences,Advanced Medicine
[3] Nagoya City University Graduate School of Medical Sciences,Department of Oncology, Immunology and Surgery
[4] Nagoya City University Graduate School of Medical Sciences,Department of Experimental Pathology and Tumor Biology
[5] Nagoya City University Hospital,Clinical Research Management Center
[6] Toyokawa City Hospital,Department of Breast and Endocrine Surgery
来源：
Breast Cancer Research and Treatment | 2021年 / 187卷
关键词：
Breast cancer; Retinoic acid-induced 2 (RAI2); Disseminated tumor cells (DTC);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：81 / 93
页数：12
相关论文
共 50 条
  • [1] Low RAI2 expression is a marker of poor prognosis in breast cancer
    Nishikawa, Sayaka
    Uemoto, Yasuaki
    Kim, Tae-Sun
    Hisada, Tomoka
    Kondo, Naoto
    Wanifuchi-Endo, Yumi
    Fujita, Takashi
    Asano, Tomoko
    Katagiri, Yusuke
    Terada, Mitsuo
    Kato, Akiko
    Dong, Yu
    Sugiura, Hiroshi
    Okuda, Katsuhiro
    Kato, Hiroyuki
    Osaga, Satoshi
    Takahashi, Satoru
    Toyama, Tatsuya
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (01) : 81 - 93
  • [2] Comprehensive analysis of the expression and prognosis for RAI2: A promising biomarker in breast cancer
    Jiao, Ying
    Li, Shiyu
    Gong, Juejun
    Zheng, Kun
    Xie, Ya
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [3] Low TINAGL1 expression is a marker for poor prognosis in breast cancer
    Akiko Kato
    Naoto Kondo
    Yumi Wanifuchi-Endo
    Takashi Fujita
    Tomoko Asano
    Tomoka Hisada
    Yasuaki Uemoto
    Mitsuo Terada
    Hiroyuki Kato
    Masayuki Komura
    Katsuhiro Okuda
    Satoru Takahashi
    Tatsuya Toyama
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 4771 - 4782
  • [4] Low TINAGL1 expression is a marker for poor prognosis in breast cancer
    Kato, Akiko
    Kondo, Naoto
    Wanifuchi-Endo, Yumi
    Fujita, Takashi
    Asano, Tomoko
    Hisada, Tomoka
    Uemoto, Yasuaki
    Terada, Mitsuo
    Kato, Hiroyuki
    Komura, Masayuki
    Okuda, Katsuhiro
    Takahashi, Satoru
    Toyama, Tatsuya
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (08) : 4771 - 4782
  • [5] Calmodulin 2 expression is associated with poor prognosis in breast cancer
    Yang, Ju
    Li, Shuixian
    Wang, Jigang
    Liu, Guoyuan
    Zhang, Chenyang
    Li, Xiaojing
    Liu, Xiuping
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 258
  • [6] Is Interleukin 10 (IL10) Expression in Breast Cancer a Marker of Poor Prognosis?
    Bhattacharjee H.K.
    Bansal V.K.
    Nepal B.
    Srivastava S.
    Dinda A.K.
    Misra M.C.
    Indian Journal of Surgical Oncology, 2016, 7 (3) : 320 - 325
  • [7] Low expression of RECQL is associated with poor prognosis in Chinese breast cancer patients
    Xu, Huiying
    Xu, Ye
    Ouyang, Tao
    Li, Jinfeng
    Wang, Tianfeng
    Fan, Zhaoqing
    Fan, Tie
    Lin, Benyao
    Xie, Yuntao
    BMC CANCER, 2018, 18
  • [8] Low expression of RECQL is associated with poor prognosis in Chinese breast cancer patients
    Huiying Xu
    Ye Xu
    Tao Ouyang
    Jinfeng Li
    Tianfeng Wang
    Zhaoqing Fan
    Tie Fan
    Benyao Lin
    Yuntao Xie
    BMC Cancer, 18
  • [9] Low expression of Mel-18 predicts poor prognosis in patients with breast cancer
    Guo, B. -H.
    Zhang, X.
    Zhang, H. -Z.
    Lin, H. -L.
    Feng, Y.
    Shao, J. -Y.
    Huang, W. -L.
    Kung, H. -F.
    Zeng, M. -S.
    ANNALS OF ONCOLOGY, 2010, 21 (12) : 2361 - 2369
  • [10] Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
    Shao, Wanting
    Kuhn, Christina
    Mayr, Doris
    Ditsch, Nina
    Kailuwait, Magdalena
    Wolf, Verena
    Harbeck, Nadia
    Mahner, Sven
    Jeschke, Udo
    Cavailles, Vincent
    Sixou, Sophie
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (09) : 2535 - 2544
12345